Cargando…
Patient’s access to healthcare and treatment in rheumatoid arthritis: the views of stakeholders in Portugal
BACKGROUND: The access to healthcare and treatment by rheumatoid arthritis (RA) patients, particularly to biologics, differs significantly among European countries. We aimed to explore the views and experiences of Portuguese healthcare stakeholders on key barriers which limit the access to treatment...
Autores principales: | Laires, Pedro A, Mesquita, Rui, Veloso, Luís, Martins, Ana Paula, Cernadas, Rui, Fonseca, João Eurico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849024/ https://www.ncbi.nlm.nih.gov/pubmed/24067096 http://dx.doi.org/10.1186/1471-2474-14-279 |
Ejemplares similares
-
Editorial: Risk factors for Rheumatoid Arthritis and pre-Rheumatoid Arthritis
por: Sapart, Emillie, et al.
Publicado: (2022) -
Response measures influence comparative effectiveness of biological drugs in rheumatoid arthritis
por: Canhao, Helena, et al.
Publicado: (2012) -
Equity in the Access of Chinese Immigrants to Healthcare Services in Portugal
por: Aparício, Sandra Lopes, et al.
Publicado: (2023) -
Disease mechanisms in preclinical rheumatoid arthritis: A narrative review
por: Romão, Vasco C., et al.
Publicado: (2022) -
JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis
por: Moura, Rita A., et al.
Publicado: (2021)